Cellular processing of 125I- and 111in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells
- 1 November 2000
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 27 (8) , 827-835
- https://doi.org/10.1016/s0969-8051(00)00148-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Conjugate Chemistry and Cellular Processing of EGF-DextranActa Oncologica, 1999
- Radiolabeling of Epidermal Growth Factor with 99mTc and in Vivo Localization following Intracerebral Injection into Normal and Glioma-Bearing RatsBioconjugate Chemistry, 1997
- Retention and processing of the monoclonal anti-prostate E4 antibody after binding to prostatic adenocarcinoma DU 145 cellsCancer Immunology, Immunotherapy, 1996
- Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptorInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Gene and chromosomal alterations associated with the development of human gliomasThe FASEB Journal, 1993
- N-Succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodinationBioconjugate Chemistry, 1991
- Effects of131I-EGF on cultured human glioma cellsJournal of Neuro-Oncology, 1990
- Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labellingInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989